VYCOR MEDICAL, INC. (VYCO)

Every figure this model derived for VYCO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 5,224 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 158,907 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 635,877 AssetsCurrent 2026-06-30
current liabilities 4,930,420 LiabilitiesCurrent 2026-06-30
equity -4,251,224 StockholdersEquity 2026-06-30
interest expense 65,405 InterestPaidNet 2026-06-30
ocf 61,384 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 1,807,473 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 48,838 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up VYCO on one particular measure came for.

RatioValue
cash operating margin8.61
current ratio0.13
current ratio reported0.13
dilution pct1.48
ebit yoy113.84
fcf margin3.11
growth cv1.13
interest cover0.74
operating margin2.67
owner earnings margin0.41
revenue growth1.61
revenue growth per share0.12
rule of 404.28
sbc pct revenue2.7

What to be careful about

What this model itself distrusts about VYCO's figures. Written by the derivation as it ran, not added afterwards.